Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Title: Phase 2, Double-Blind, Placebo-Controlled Trial Of Bupropion For Methamphetamine Dependence      
ID:
NIDA-MDS-0007
creators:
Ann Anderson, M.D.
privacy:
information not available
keywords:
phase 2b; methamphetamine; bupropion; stimulant
refinement:
curated
types:
clinical trial
dateReleased:
12-04-2014
aggregation:
instance of dataset
availability:
available
description:
The primary objective of this study is to assess the efficacy of bupropion in reducing methamphetamine use in subjects with methamphetamine dependence who report using methamphetamine 29 or less days during the 30 day prior to signing consent. It is hypothesized that bupropion, compared to placebo, will be associated with an increase in the proportion of subjects who achieve abstinence (confirmed by at least two methamphetamine negative urines) each week during the last two weeks (Weeks 11 and 12) for non-daily users as the primary outcome.
name:
Homo sapiens
ID:
SCR:011440
homePage: http://www.nida.nih.gov/
abbreviation:
NIDA
name:
National Institute on Drug Abuse
ID:
SCR:002002
homePage: http://datashare.nida.nih.gov/
abbreviation:
CTN
name:
Clinical Trials Network Data Share

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on GitHub.